357 related articles for article (PubMed ID: 25967924)
1. Laxatives for the management of constipation in people receiving palliative care.
Candy B; Jones L; Larkin PJ; Vickerstaff V; Tookman A; Stone P
Cochrane Database Syst Rev; 2015 May; 2015(5):CD003448. PubMed ID: 25967924
[TBL] [Abstract][Full Text] [Related]
2. Laxatives or methylnaltrexone for the management of constipation in palliative care patients.
Candy B; Jones L; Goodman ML; Drake R; Tookman A
Cochrane Database Syst Rev; 2011 Jan; (1):CD003448. PubMed ID: 21249653
[TBL] [Abstract][Full Text] [Related]
3. Laxatives for the management of constipation in palliative care patients.
Miles CL; Fellowes D; Goodman ML; Wilkinson S
Cochrane Database Syst Rev; 2006 Oct; (4):CD003448. PubMed ID: 17054172
[TBL] [Abstract][Full Text] [Related]
4. Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.
Candy B; Jones L; Vickerstaff V; Larkin PJ; Stone P
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006332. PubMed ID: 29869799
[TBL] [Abstract][Full Text] [Related]
5. Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).
Gordon M; Naidoo K; Akobeng AK; Thomas AG
Evid Based Child Health; 2013 Jan; 8(1):57-109. PubMed ID: 23878124
[TBL] [Abstract][Full Text] [Related]
6. Osmotic and stimulant laxatives for the management of childhood constipation.
Gordon M; MacDonald JK; Parker CE; Akobeng AK; Thomas AG
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD009118. PubMed ID: 27531591
[TBL] [Abstract][Full Text] [Related]
7. Osmotic and stimulant laxatives for the management of childhood constipation.
Gordon M; Naidoo K; Akobeng AK; Thomas AG
Cochrane Database Syst Rev; 2012 Jul; (7):CD009118. PubMed ID: 22786523
[TBL] [Abstract][Full Text] [Related]
8. [Is the pharmacological treatment of constipation in palliative care evidence based? : a systematic literature review].
Bader S; Weber M; Becker G
Schmerz; 2012 Sep; 26(5):568-86. PubMed ID: 23052993
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological treatment of constipation in palliative care.
Clemens KE; Faust M; Jaspers B; Mikus G
Curr Opin Support Palliat Care; 2013 Jun; 7(2):183-91. PubMed ID: 23478431
[TBL] [Abstract][Full Text] [Related]
11. Comparison of "Duphalac" and "irritant" laxatives during and after treatment of chronic constipation: a preliminary study.
Connolly P; Hughes IW; Ryan G
Curr Med Res Opin; 1974-1975; 2(10):620-5. PubMed ID: 4616802
[TBL] [Abstract][Full Text] [Related]
12. Interventions for preventing postpartum constipation.
Turawa EB; Musekiwa A; Rohwer AC
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD011625. PubMed ID: 26387487
[TBL] [Abstract][Full Text] [Related]
13. Management of constipation in patients receiving palliative care.
Cayley WE
Am Fam Physician; 2011 Dec; 84(11):1227-8. PubMed ID: 22150655
[No Abstract] [Full Text] [Related]
14. Laxatives or methylnaltrexone for the management of constipation in palliative care patients.
Brick N
Clin J Oncol Nurs; 2013 Feb; 17(1):91-2. PubMed ID: 23372103
[No Abstract] [Full Text] [Related]
15. Efficacy and side-effect profiles of lactulose, docusate sodium, and sennosides compared to PEG in opioid-induced constipation: a systematic review.
Ruston T; Hunter K; Cummings G; Lazarescu A
Can Oncol Nurs J; 2013; 23(4):236-46. PubMed ID: 24428006
[TBL] [Abstract][Full Text] [Related]
16. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness.
Chamberlain BH; Cross K; Winston JL; Thomas J; Wang W; Su C; Israel RJ
J Pain Symptom Manage; 2009 Nov; 38(5):683-90. PubMed ID: 19713070
[TBL] [Abstract][Full Text] [Related]
17. Evidence Based Review of Pharmacotherapy for Opioid-Induced Constipation in Noncancer Pain.
Murphy JA; Sheridan EA
Ann Pharmacother; 2018 Apr; 52(4):370-379. PubMed ID: 29092627
[TBL] [Abstract][Full Text] [Related]
18. Subsidised use of methylnaltrexone in Australia for palliative care.
Rowett DS; Clark K; Robinson MK; Currow DC
Med J Aust; 2012 Nov; 197(9):492. PubMed ID: 23121581
[No Abstract] [Full Text] [Related]
19. Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness.
Diego L; Atayee R; Helmons P; von Gunten CF
Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):473-85. PubMed ID: 19817669
[TBL] [Abstract][Full Text] [Related]
20. Management of opioid-induced constipation in cancer patients: focus on methylnaltrexone.
Gatti A; Sabato AF
Clin Drug Investig; 2012 May; 32(5):293-301. PubMed ID: 22413747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
